Effect of Acupuncture on Chronic Pain with Depression: A Systematic Review

Yan et al. · Evidence-Based Complementary and Alternative Medicine · 2020

📊Systematic Review with Meta-analysis👥n=535 participantsModerate Evidence

Evidence Level

MODERATE
65/ 100
Quality
3/5
Sample
3/5
Replication
4/5
🎯

OBJECTIVE

Evaluate the efficacy of acupuncture in the treatment of chronic pain associated with depression

👥

WHO

Patients with concomitant chronic pain and depression

⏱️

DURATION

Studies of 4 to 8 weeks of treatment

📍

POINTS

Local points for pain and points such as GV-20, GV-24, PC-6, HT-7 for depression

🔬 Study Design

535participants
randomization

Acupuncture (alone or combined)

n=265

Acupuncture with or without medication

Control (medication)

n=270

Antidepressant or analgesic medication only

⏱️ Duration: 4 to 8 weeks

📊 Results in numbers

-0.68 points

Reduction on VAS pain scale

-2.18 points

Reduction on HAM-D depression scale

p = 0.02

Statistical significance for pain

p < 0.00001

Statistical significance for depression

Significant reduction

Fewer adverse effects in acupuncture group

📊 Outcome Comparison

Visual Analog Pain Scale (VAS)

Acupuncture
2.5
Control
3.2

Hamilton Depression Rating Scale (HAM-D)

Acupuncture
10.5
Control
12.7
💬 What does this mean for you?

This review analyzed 7 studies involving 535 people who had chronic pain and depression at the same time. The results show that acupuncture, used alone or together with medications, was more effective than medications alone in reducing both pain and symptoms of depression, with fewer side effects.

📝

Article summary

Plain-language narrative summary

The combination of chronic pain and depression is extremely common and challenging in medical practice. Approximately 30% to 45% of patients with chronic pain present symptoms of depression, while 52% to 65% of people with depression suffer from chronic pain. This dual condition creates a vicious cycle in which pain worsens depressive symptoms, and depression intensifies pain perception. Studies show that both conditions share similar neurotransmitters and nerve pathways in the brain.

Treating this combination is particularly difficult because patients often respond poorly to conventional medications and face significant side effects. Pain medications, such as opioids, can cause dependence and even increase the risk of depression. Antidepressants, in turn, may interact with analgesics and cause adverse effects. This makes it urgent to find safer and more effective therapeutic alternatives.

This study aimed to systematically evaluate the efficacy of acupuncture in the treatment of chronic pain associated with depression. The researchers conducted a comprehensive search in six scientific databases, including PubMed, Cochrane Library, EMBASE, and other Chinese databases, looking for studies published through March 2020. Only randomized controlled trials comparing acupuncture alone or combined with other treatments versus conventional treatments without acupuncture were included. Participants were required to have a confirmed diagnosis of chronic pain and depression.

The main outcomes assessed were the Visual Analog Scale for pain, where higher scores indicate more pain, and the Hamilton Depression Rating Scale, where higher scores indicate greater severity of depression. Adverse events were also recorded to evaluate the safety of the treatments. Statistical analysis was conducted using standardized methods for systematic reviews.

The research initially identified 535 studies, of which only seven randomized controlled trials met the rigorous inclusion criteria, involving 535 patients in total. Of these, 265 participants received acupuncture alone or combined with other treatments, while 270 received only conventional treatments. All studies were conducted in China and published between 2000 and 2018. The results showed significant improvement in both pain and depression in the group that received acupuncture.

Specifically, the reduction on the pain scale was 0.68 points greater in the acupuncture group compared to the control group, while the improvement on the depression scale was even more impressive, with a reduction of 2.18 points. Additionally, patients who received acupuncture experienced fewer side effects. While the medication group had adverse events in 16% to 67% of cases, the acupuncture group had only 0% to 36% adverse effects, demonstrating greater treatment safety.

These findings have important implications for patients and health professionals. Acupuncture proved to be not only more effective than conventional treatments alone but also safer. For patients suffering from this debilitating condition—especially those who do not respond well to medications or experience severe side effects—acupuncture represents a valuable alternative. Treatment costs are also generally lower than long-term medications.

For health professionals, these results suggest that acupuncture can be integrated into the therapeutic plan as a complementary or alternative treatment. Importantly, acupuncture worked well both alone and combined with medications, offering flexibility in the therapeutic approach. The studies analyzed used different acupuncture points, but frequently included local points near the area of pain and distal points related to emotional well-being according to traditional Chinese medicine.

Despite the promising results, the study presents important limitations that should be considered. The methodological quality of most of the included studies was considered low, with only one of the seven studies receiving a high score on the quality criteria. Due to the characteristics of acupuncture, it is difficult to implement fully blinded studies, which may influence the results. Additionally, all studies were conducted in China, limiting the generalization of the results to other populations.

The different acupuncture protocols used in the studies also make it difficult to establish standardized treatment guidelines. The relatively small number of studies and participants also limits the strength of the conclusions. Therefore, although the results are encouraging, more high-quality studies with larger samples and long-term follow-up are needed to definitively confirm the efficacy of acupuncture in this specific condition and to establish more precise treatment protocols.

Strengths

  • 1First systematic review on acupuncture for chronic pain with depression
  • 2Comprehensive search across multiple databases
  • 3Safety analysis included
  • 4Consistent results across different studies
  • 5Rigorous methodology for study selection
⚠️

Limitations

  • 1Low methodological quality of most included studies
  • 2High heterogeneity among studies (I² = 85% for pain)
  • 3All studies conducted in China, limiting generalization
  • 4Inability to blind due to the nature of acupuncture
  • 5Short-term follow-up (4-8 weeks only)
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

The overlap between chronic pain and depression is one of the most challenging scenarios in pain and rehabilitation services. The prevalence of this comorbidity—with up to 45% of chronic pain patients presenting depression—turns each consultation into a complex decision-making exercise, especially given the limitations and interactions of conventional drugs. This systematic review formalizes something that physicians working with musculoskeletal pain already observe in practice: acupuncture offers a route of simultaneous action on both conditions, with a safety profile superior to isolated pharmacological treatment. For the patient who does not tolerate antidepressants, who already takes long-term analgesics, or who has a partial response to medication, acupuncture fits as an adjunct or as a primary alternative, expanding the therapeutic arsenal without adding drug-interaction risks.

Notable Findings

The most striking finding is not the magnitude of pain reduction—the 0.68 points on VAS are modest, but statistically robust at p = 0.02—but rather the 2.18-point reduction on the Hamilton Depression Rating Scale (HAM-D), with p < 0.00001. This degree of statistical significance for the psychiatric outcome, in a population with established comorbidity, suggests that acupuncture acts on shared pathways between nociception and mood regulation, possibly via serotonergic modulation and the hypothalamic-pituitary-adrenal axis. The safety data are equally relevant: the rate of adverse events in the acupuncture group was between 0% and 36%, compared with 16% to 67% in the medication group. In a context where treatment dropout due to side effects is a real problem, this difference has direct impact on adherence and continuity of treatment.

From My Experience

In my pain service practice, patients with this pain-depression comorbidity form a subgroup I usually call "patients of difficult pharmacological management"—they often arrive already taking two or three analgesics, an antidepressant at a subtherapeutic dose, and complaining of gastrointestinal or cognitive side effects. I have observed that, in this profile, the response to acupuncture begins to appear between the third and fifth session, with improvement in sleep and mood before any relevant change in pain. I usually work with protocols of 10 to 12 sessions for the acute phase, combining acupuncture with supervised aerobic exercise—the combination seems to consistently potentiate the effects on mood. The patient who responds best, in my experience, is the one with chronic pain that has a relevant myofascial component and mild to moderate, non-psychotic depression. We do not recommend acupuncture as monotherapy when there is suicide risk or severe depression that is not pharmacologically treated—in those cases, it enters as an adjunct after psychiatric stabilization.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Evidence-Based Complementary and Alternative Medicine · 2020

DOI: 10.1155/2020/7479459

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.